BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36414984)

  • 1. An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study.
    Wu L; Ye W; Liu Y; Chen D; Wang Y; Cui Y; Li Z; Li P; Li Z; Liu Z; Liu M; Liang C; Yang X; Xie Y; Wang Y
    Breast Cancer Res; 2022 Nov; 24(1):81. PubMed ID: 36414984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
    Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
    Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
    Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
    EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
    Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
    Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer:A multicenter study.
    Li B; Li F; Liu Z; Xu F; Ye G; Li W; Zhang Y; Zhu T; Shao L; Chen C; Sun C; Qiu B; Bu H; Wang K; Tian J
    Breast; 2022 Dec; 66():183-190. PubMed ID: 36308926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
    Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
    Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
    Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies.
    Saednia K; Tran WT; Sadeghi-Naini A
    Med Phys; 2023 Dec; 50(12):7852-7864. PubMed ID: 37403567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.
    Zhang J; Wu Q; Yin W; Yang L; Xiao B; Wang J; Yao X
    BMC Cancer; 2023 May; 23(1):431. PubMed ID: 37173635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of pCR and chemosensitivity for breast cancer patients using DLG3, RADL and Pathomics signatures based on machine learning and deep learning.
    Jiang C; Zhang X; Qu T; Yang X; Xiu Y; Yu X; Zhang S; Qiao K; Meng H; Li X; Huang Y
    Transl Oncol; 2024 May; 46():101985. PubMed ID: 38805774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Branch Convolutional Neural Network Based on Ultrasound Imaging in the Early Prediction of Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer.
    Xie J; Shi H; Du C; Song X; Wei J; Dong Q; Wan C
    Front Oncol; 2022; 12():812463. PubMed ID: 35463368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
    Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
    Joo S; Ko ES; Kwon S; Jeon E; Jung H; Kim JY; Chung MJ; Im YH
    Sci Rep; 2021 Sep; 11(1):18800. PubMed ID: 34552163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study.
    Zhang J; Cui Y; Wei K; Li Z; Li D; Song R; Ren J; Gao X; Yang X
    Gastric Cancer; 2022 Nov; 25(6):1050-1059. PubMed ID: 35932353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
    El Adoui M; Drisis S; Benjelloun M
    Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
    Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
    EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.